Targeting different binding sites in the CFTR structures allows to synergistically potentiate channel activity
- 1 March 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 190, 112116
Abstract
No abstract availableKeywords
Funding Information
- Association Vaincre la Mucoviscidose
This publication has 92 references indexed in Scilit:
- Discovery of novel potent ΔF508‐CFTR correctors that target the nucleotide binding domainEMBO Molecular Medicine, 2013
- Correction of Both NBD1 Energetics and Domain Interface Is Required to Restore ΔF508 CFTR Folding and FunctionCell, 2012
- Privileged scaffolds for library design and drug discoveryCurrent Opinion in Chemical Biology, 2010
- CHARMM general force field: A force field for drug‐like molecules compatible with the CHARMM all‐atom additive biological force fieldsJournal of Computational Chemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Mutations at Arginine 352 Alter the Pore Architecture of CFTRThe Journal of Membrane Biology, 2008
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- UCSF Chimera—A visualization system for exploratory research and analysisJournal of Computational Chemistry, 2004
- Extending the treatment of backbone energetics in protein force fields: Limitations of gas‐phase quantum mechanics in reproducing protein conformational distributions in molecular dynamics simulationsJournal of Computational Chemistry, 2004
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996